Insider · CIK 0001434095

Tessmer James F

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001434095

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-15	LXRXLEXICON PHARMACEUTICALS, INC.S Sale	VP, Finance & Accounting	SSale	−10.9K sh	$6.90	−$75.3K	71,766
2021-03-15	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+12K sh	$3.31	+$39.7K	83,766
2021-03-15	LXRXLEXICON PHARMACEUTICALS, INC.S Sale	VP, Finance & Accounting	SSale	−12K sh	$6.92	−$83.1K	71,766
2021-03-15	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−12K sh	—	—	50,980
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+1,270 sh	—	—	66,397
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+4,213 sh	—	—	70,610
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+8,836 sh	—	—	79,446
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+14K sh	—	—	93,443
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance & Accounting	FTax Payment	−10.8K sh	$7.19	−$77.4K	82,678
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−1,270 sh	—	—	0
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−4,213 sh	—	—	0
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−8,836 sh	—	—	8,837
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−14K sh	—	—	27,993
2021-02-11	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance & Accounting	AAward	+16.2K sh	—	—	16,230
2021-02-11	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance & Accounting	AAward	+24.3K sh	—	—	24,340
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.A Award	VP, Finance & Accounting	AAward	+13.3K sh	—	—	69,124
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance & Accounting	FTax Payment	−3,997 sh	$1.96	−$7,834.12	65,127
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+2,075 sh	—	—	45,443
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+1,270 sh	—	—	46,713
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+4,214 sh	—	—	50,927
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+8,837 sh	—	—	59,764
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance & Accounting	FTax Payment	−3,902 sh	$2.77	−$10.8K	55,862
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−2,075 sh	—	—	0
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−1,270 sh	—	—	1,270
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−4,214 sh	—	—	4,213
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−8,837 sh	—	—	17,673
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance & Accounting	AAward	+42K sh	—	—	41,990
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance & Accounting	AAward	+63K sh	—	—	62,980
2019-08-02	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	VP, Finance & Accounting	PPurchase	+10K sh	$1.14	+$11.4K	43,368
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+2,668 sh	—	—	28,311
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+2,075 sh	—	—	30,386
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+1,270 sh	—	—	31,656
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+4,213 sh	—	—	35,869
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance & Accounting	FTax Payment	−2,501 sh	$5.51	−$13.8K	33,368
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−2,668 sh	—	—	0
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−2,075 sh	—	—	2,075
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−1,270 sh	—	—	2,540
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−4,213 sh	—	—	8,427
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance & Accounting	AAward	+39.8K sh	—	—	39,770
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance & Accounting	AAward	+26.5K sh	—	—	26,510
2018-06-08	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+10K sh	$10.15	+$102K	35,643
2018-06-08	LXRXLEXICON PHARMACEUTICALS, INC.S Sale	VP, Finance & Accounting	SSale	−10K sh	$12.91	−$129K	25,643
2018-06-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−10K sh	—	—	11,428
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+1,340 sh	—	—	21,435
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+2,668 sh	—	—	24,103
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+2,075 sh	—	—	26,178
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	+1,270 sh	—	—	27,448
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance & Accounting	FTax Payment	−1,805 sh	$8.53	−$15.4K	25,643
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−1,340 sh	—	—	0
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance & Accounting	MExercise/Conversion	−2,668 sh	—	—	2,668

Recent filings

Accepted (ET)
Mar 164
Tessmer James F0001127602-21-010892
SEC(opens sec.gov)
Mar 24
Tessmer James F0001127602-21-008775
SEC(opens sec.gov)
Feb 164
Tessmer James F0001127602-21-005838
SEC(opens sec.gov)
Apr 244
Tessmer James F0001127602-20-014493
SEC(opens sec.gov)
Mar 34
Tessmer James F0001127602-20-008967
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.VP, Finance & AccountingLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160